E. Salanouve et al. / Tetrahedron 68 (2012) 3165e3171
3171
64.8; 96.2; 117.6; 121.4; 128.3; 130.0 (two signals); 134.2; 138.1;
3.95 (s, 3H); 5.81 (s, 1H); 7.36 (m, 2H); 7.70 (m, 2H). 13C NMR
143.9; 148.0; 152.4; 163.8. HRMS-ES: m/z [MþH]þ calcd for
(100 MHz, CDCl3):
d
¼33.7; 58.6; 81.5; 126.4; 128.6; 132.4; 133.2;
35
35
C16H
ClN3O: 300.0904; found: 300.0872.
148.1; 156.2. HRMS-ES: m/z [MþH]þ calcd for C11
H ClN2O:
12
15
223.0638; found: 223.0595.
4.2.23. 5-(4-Chlorophenyl)-1-(pyridin-2-yl)-1H-pyrazol-3(2H)-one
(33). By using exactly the same protocol described above for the
synthesis of 27, either from the 3-methoxypyrazole 32 or from the
3-ethoxypyrazole 35 (0.1 g, 0.33 mmol), compound 33 was ob-
tained as a white powder (0.06 g, 79%). Mp 261 ꢀC 1H NMR
Acknowledgements
This work was supported by the Medicen initiative (Chemical
Library Project; grant of the Region Ile de France n I 06-222/R and I
09-1739/R, which included a fellowship for S.G.) and a grant from
the DARRI (Institut Pasteur). Dr. Daniel Larzul as well as Dr. Emile
Bisagni are also acknowledged for their interest and support.
ꢀ
(400 MHz, DMSO-d6):
7.61 (d, J¼8.2 Hz, 1H); 7.92 (m, 1H); 8.16 (m, 1H); 10.39 (s(br), 1H).
13C NMR (100 MHz, DMSO-d6):
¼97.1; 117.6; 122.2; 128.5; 130.5;
d¼5.99 (s, 1H); 7.24 (m, 3H); 7.39 (m, 2H);
d
130.7; 133.1; 139.3; 143.4; 147.9; 152.5; 162.4. HRMS-ES: m/z
35
[MþH]þ calcd for C14
H ClN3O: 272.0591; found: 272.0542.
11
References and notes
4.3. Arylation of methoxypyrazole 25 using Taillefer and
Cristau method
1. Guillou, S.; Bonhomme, F. J.; Janin, Y. L. Synthesis 2008, 3504e3508.
2. Guillou, S.; Nesme, O.; Ermolenko, M. S.; Janin, Y. L. Tetrahedron 2009, 65,
3529e3535.
3. Guillou, S.; Bonhomme, F. J.; Janin, Y. L. Tetrahedron 2009, 65, 2660e2668.
4. Guillou, S.; Janin, Y. L. Chem. Eur. J. 2010, 16, 4669e4677.
5. Guillou, S.; Bonhomme, F. J.; Chahine, D.; Nesme, O.; Janin, Y. L. Tetrahedron
2010, 66, 2654e2663.
6. Salanouve, E.; Retailleau, P.; Janin, Y. L. Tetrahedron 2012, 68, 2135e2140.
7. Guillou, S.; Bonhomme, F. J.; Ermolenko, M. S.; Janin, Y. L. Tetrahedron 2011, 67,
8451e8457.
In a 20 mL Biotage tube compound 25 (0.54 g, 2.58 mmol), 2-
bromopyridine (0.27 mL, 2.84 mmol), cesium carbonate (0.93 g,
0
ꢁ
2.84.5 mmol), 4 A molecular sieves (0.4 g, 3.2 mm pellets), [N,N -
bis-((20-pyridine)-methylene)]-1,2-diaminocyclohexane28 (0.075 g,
ꢁ
0.24 mmol) were dispersed in acetonitrile (10 mL, dried over 4 A
molecular sieves). This was degassed using a slow stream of argon
bubbling in the suspension. Copper oxide (0.018 g, 0.12 mmol) was
then added and the tube was sealed. This was shaken thoroughly,
heated for 30 s in the microwave oven at 100 ꢀC and shaken again.
At this stage the pink copper oxide is well dissolved in the reaction
mixture; if not, another 30 s heating at 100 ꢀC is required. The
heating is then resumed at 180 ꢀC for 2 h. The crude reaction
mixture was concentrated to dryness and directly purified by a first
chromatography over alumina containing 1.5% of water (cyclo-
hexane/ethyl acetate from 99/1 to 9/1). This led, in order of elution,
to a fraction containing compound 39, 40, and 31 and a second one
containing pure compound 38 (0.09 g, 12). The first fraction was
subjected to a second chromatography over silica gel (cyclohexane/
dichloromethane from 1/2 to 0/1) to yield, in order of elution,
compound 40 (0.05 g, 8.6%), compound 39 (0.02 g, 3.4%) and
compound 31 (0.12 g, 14.8%) as described above.
8. Middleton, W. J.; Engelhardt, V. A. J. Am. Chem. Soc. 1958, 80, 2829e2832.
9. Chauhan, S. M. S.; Junjappa, H. Synthesis 1975, 798e801.
10. Martins, M. A. P.; Pereira, C. M. P.; Zimmermann, N. E. K.; Cunico, W.; Moura, S.;
Beck, P.; Zanatta, N.; Bonacorso, H. G. J. Fluorine Chem. 2003, 123, 261e265.
11. Neidlen, R.; Kikelj, D.; Kramer, W. J. Heterocycl. Chem. 1989, 26, 1335e1340.
12. Stachel, H.-D.; Papenberg, G. Arch. Pharmacol. 1981, 314, 65e71.
13. Porter, H.D.; Weissberger, A.; Gregory, W.A. U.S. Patent 2,439,098.
14. Tang, F. Patent CN 2006-10012859.
15. Morita, Y.; Samejima, Y.; Shimada, S. Patent JP 7372176.
16. Martins, M. A. P.; Cunico, W.; Brondani, S.; Peres, R. L.; Zimmermann, N.; Rosa,
F. A.; Fiss, G. F.; Zanatta, N.; Bonacorso, H. G. Synthesis 2006, 1485e1493.
17. Hojo, M.; Masuda, R.; Okada, E. Synthesis 1986, 1013e1014.
18. Guenther, K.; Mau, G. U.S. Patent 4,825,008.
19. Guenther, K. U.S. Patent 4967012.
20. Nesmeyanov, A. N.; Reutov, O. A.; Gudkova, A. S. Izv. Akad. Nauk. SSSR, Ser. Khim
1961, 260e264.
21. Pochat, F.; Levas, E. Bull. Soc. Chim. Fr. 1972, 8, 3151e3156.
22. Banville, J.; Brassard, P. J. Chem. Soc., Perkin Trans. I 1976, 1852e1856.
23. McElvain, S. M.; Kundiger, D. J. Am. Chem. Soc. 1942, 64, 254e259.
24. McElvain, S. M.; McKay, G. R. J. Am. Chem. Soc. 1956, 78, 6086e6091.
25. Opitz, G.; Zimmermann, F. Chem. Ber. 1964, 97, 1266e1274.
26. Varvounis, G.; Fiamegos, Y.; Pilidis, G. Pyrazol-3-ones, part 1: synthesis and
applications In; Katritzky, A. R., Ed. . Adv. Heterocyclic Chem.; Academic: 2001;
vol. 80, pp 74e144.
4.3.1. 2-(3-(4-Chlorophenyl)-5-methoxy-1H-pyrazol-1-yl)pyridine
(38). Obtained as a solid. Mp 76 ꢀC 1H NMR (400 MHz, CDCl3):
d
¼4.08 (s, 3H); 6.04 (s, 1H); 7.25 (m, 1H); 7.42 (m, 2H); 7.82 (m, 4H);
27. Stanovik, E.; Svete, J. Product class 1: pyrazoles In; Neier, R., Ed. . Science of
Synthesis; Thieme: 2002; vol. 12, pp 15e225.
28. Cristau, H. J.; Cellier, P. P.; Hamada, S.; Spindler, J. F.; Taillefer, M. Org. Lett. 2004,
6, 913e916.
29. Cristau, H. J.; Cellier, P. P.; Spindler, J. F.; Taillefer, M. Chem.dEur. J. 2004, 10,
5607e5622.
8.61 (m, 1H). 13C NMR (100 MHz, CDCl3):
d
¼59.4; 84.1; 116.7; 121.5;
127.0; 128.7; 131.6; 134.1; 138.2; 148.6; 150.4; 151.5; 157.2. HRMS-
35
ES: m/z [MþH]þ calcd for C15
H ClN3O: 286.0747; found: 286.0698.
13
30. Cristau, H. J.; Cellier, P. P.; Spindler, J. F.; Taillefer, M. Eur. J. Org. Chem. 2004,
695e709.
31. Jasserand, D.; Christen, M.-O.; Biard, D.; Yavordios, D. U.S. Patent 4672063.
32. McElvain, S. M.; Anthes, H. I.; Shapiro, S. H. J. Am. Chem. Soc. 1942, 64,
2525e2531.
33. McElvain, S. M.; McShane, H. F. J. Am. Chem. Soc. 1952, 74, 2662e2667.
34. McElvain, S. M.; Kundiger, D. Org. Synth. Coll. Vol. III; 1955, 506e508.
35. Taskinen, E.; Pentikainen, M. L. Tetrahedron 1978, 34, 2365e2370.
36. Dehmlow, E. V.; Veretenov, A. L. Synthesis 1992, 939e940.
37. Argade, A. B.; Joglekar, B. R. Synth. Commun. 1993, 23, 1979e1984.
38. Zheng, Q.-H.; Su, J. Synth. Commun. 1999, 29, 3467e3476.
39. Kesteleyn, B.; De Kimpe, N. J. Org. Chem. 2000, 65, 635e639.
4.3.2. 5-(4-Chlorophenyl)-3-methoxy-1-methyl-1H-pyrazole
(39). Obtained as a solid. Mp 51 ꢀC 1H NMR (400 MHz, CDCl3):
d
¼3.71 (s, 3H); 3.91 (s, 3H); 5.72 (s, 1H); 7.34 (m, 2H); 7.42 (m, 2H).
13C NMR (100 MHz, CDCl3):
d
¼36.9; 56.2; 90.5; 128.9; 129.1; 130.0;
35
134.7; 144.0; 163.0. HRMS-ES: m/z [MþH]þ calcd for C11
H ClN2O:
12
223.0638; found: 223.0583.
4.3.3. 3-(4-Chlorophenyl)-5-methoxy-1-methyl-1H-pyrazole
(40). Obtained as an oil. 1H NMR (400 MHz, CDCl3):
¼3.69 (s, 3H);
d